PG
AMGN icon

Prostatis Group’s Amgen AMGN Stock Holding History

Prostatis Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$601K Buy
1,707
+81
+5% +$28.9K 0.15% 97
2025
Q4 		$532K Sell
1,626
-34
-2% -$10.8K 0.13% 101
2025
Q3 		$469K Sell
1,660
-64
-4% -$18.6K 0.12% 99
2025
Q2 		$481K Sell
1,724
-141
-8% -$39.9K 0.14% 98
2025
Q1 		$581K Sell
1,865
-456
-20% -$135K 0.18% 88
2024
Q4 		$605K Sell
2,321
-77
-3% -$22.8K 0.18% 93
2024
Q3 		$773K Buy
2,398
+222
+10% +$72.6K 0.25% 73
2024
Q2 		$680K Buy
2,176
+332
+18% +$97.5K 0.24% 81
2024
Q1 		$524K Buy
1,844
+527
+40% +$154K 0.2% 92
2023
Q4 		$379K Sell
1,317
-26
-2% -$7.08K 0.16% 96
2023
Q3 		$361K Sell
1,343
-53,633
-98% -$13.4M 0.18% 75
2023
Q2 		$323K Buy
54,976
+49,215
+854% +$11.4M 0.15% 86
2023
Q1 		$1.38M Sell
5,761
-370
-6% -$90.8K 0.73% 34
2022
Q4 		$1.61M Buy
6,131
+331
+6% +$88.7K 0.98% 28
2022
Q3 		$1.31M Buy
5,800
+4,596
+382% +$1.11M 1.51% 21
2022
Q2 		$293K Buy
1,204
+39
+3% +$9.56K 0.46% 25
2022
Q1 		$282K Buy
1,165
+10
+0.9% +$2.3K 0.23% 61
2021
Q4 		$260K Buy
1,155
+9
+0.8% +$1.9K 0.16% 85
2021
Q3 		$244K Sell
1,146
-41
-3% -$9.44K 0.15% 88
2021
Q2 		$289K Sell
1,187
-233
-16% -$57.3K 0.2% 85
2021
Q1 		$353K Buy
1,420
+33
+2% +$7.87K 0.28% 79
2020
Q4 		$319K Buy
1,387
+136
+11% +$31.4K 0.27% 65
2020
Q3 		$318K Buy
1,251
+66
+6% +$16.4K 0.3% 64
2020
Q2 		$279K Buy
1,185
+12
+1% +$2.74K 0.56% 52
2020
Q1 		$238K Sell
1,173
-47
-4% -$10.3K 0.34% 42
2019
Q4 		$294K Buy
+1,220
New +$269K 0.27% 65

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Prostatis Group's AMGN Position: Q1 2026 in Review

Prostatis Group increased its Amgen (AMGN) stake by 5% in Q1 2026, buying an estimated $28.9K and bringing the position to 1,707 shares worth $601K. The position accounts for 0.15% of the portfolio, ranked #97.

Prostatis Group first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.61M in Q4 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Prostatis Group held 1,707 shares of Amgen worth $601K as of Q1 2026.
  • Prostatis Group bought 81 Amgen shares in Q1 2026, an estimated $28.9K.
  • Amgen made up 0.15% of Prostatis Group's portfolio in Q1 2026, its #97 holding.
  • Prostatis Group first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • Prostatis Group's Amgen position peaked at $1.61M in Q4 2022.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.